Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55

Oxidative stress is associated with different neurological and psychiatric diseases. Therefore, development of new pharmaceuticals targeting oxidative dysregulation might be a promising approach to treat these diseases. The G-protein coupled receptor 55 (GPR55) is broadly expressed in central nervou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthias Apweiler, Soraya Wilke Saliba, Jana Streyczek, Thomas Hurrle, Simone Gräßle, Stefan Bräse, Bernd L. Fiebich
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
ROS
Acceso en línea:https://doaj.org/article/53573912c7d940c28090b1526114831b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:53573912c7d940c28090b1526114831b
record_format dspace
spelling oai:doaj.org-article:53573912c7d940c28090b1526114831b2021-11-11T17:07:53ZTargeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR5510.3390/ijms2221116651422-00671661-6596https://doaj.org/article/53573912c7d940c28090b1526114831b2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11665https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Oxidative stress is associated with different neurological and psychiatric diseases. Therefore, development of new pharmaceuticals targeting oxidative dysregulation might be a promising approach to treat these diseases. The G-protein coupled receptor 55 (GPR55) is broadly expressed in central nervous tissues and cells and is involved in the regulation of inflammatory and oxidative cell homeostasis. We have recently shown that coumarin-based compounds enfold inverse agonistic activities at GPR55 resulting in the inhibition of prostaglandin E<sub>2</sub>. However, the antioxidative effects mediated by GPR55 were not evaluated yet. Therefore, we investigated the antioxidative effects of two novel synthesized coumarin-based compounds, KIT C and KIT H, in primary mouse microglial and human neuronal SK-N-SK cells. KIT C and KIT H show antioxidative properties in SK-N-SH cells as well as in primary microglia. In GPR55-knockout SK-N-SH cells, the antioxidative effects are abolished, suggesting a GPR55-dependent antioxidative mechanism. Since inverse agonistic GPR55 activation in the brain seems to be associated with decreased oxidative stress, KIT C and KIT H possibly act as inverse agonists of GPR55 eliciting promising therapeutic options for oxidative stress related diseases.Matthias ApweilerSoraya Wilke SalibaJana StreyczekThomas HurrleSimone GräßleStefan BräseBernd L. FiebichMDPI AGarticleoxidative stressGPR55coumarin-based compoundsROSinverse agonism8-Iso-PGF<sub>2α</sub>Biology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11665, p 11665 (2021)
institution DOAJ
collection DOAJ
language EN
topic oxidative stress
GPR55
coumarin-based compounds
ROS
inverse agonism
8-Iso-PGF<sub>2α</sub>
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle oxidative stress
GPR55
coumarin-based compounds
ROS
inverse agonism
8-Iso-PGF<sub>2α</sub>
Biology (General)
QH301-705.5
Chemistry
QD1-999
Matthias Apweiler
Soraya Wilke Saliba
Jana Streyczek
Thomas Hurrle
Simone Gräßle
Stefan Bräse
Bernd L. Fiebich
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
description Oxidative stress is associated with different neurological and psychiatric diseases. Therefore, development of new pharmaceuticals targeting oxidative dysregulation might be a promising approach to treat these diseases. The G-protein coupled receptor 55 (GPR55) is broadly expressed in central nervous tissues and cells and is involved in the regulation of inflammatory and oxidative cell homeostasis. We have recently shown that coumarin-based compounds enfold inverse agonistic activities at GPR55 resulting in the inhibition of prostaglandin E<sub>2</sub>. However, the antioxidative effects mediated by GPR55 were not evaluated yet. Therefore, we investigated the antioxidative effects of two novel synthesized coumarin-based compounds, KIT C and KIT H, in primary mouse microglial and human neuronal SK-N-SK cells. KIT C and KIT H show antioxidative properties in SK-N-SH cells as well as in primary microglia. In GPR55-knockout SK-N-SH cells, the antioxidative effects are abolished, suggesting a GPR55-dependent antioxidative mechanism. Since inverse agonistic GPR55 activation in the brain seems to be associated with decreased oxidative stress, KIT C and KIT H possibly act as inverse agonists of GPR55 eliciting promising therapeutic options for oxidative stress related diseases.
format article
author Matthias Apweiler
Soraya Wilke Saliba
Jana Streyczek
Thomas Hurrle
Simone Gräßle
Stefan Bräse
Bernd L. Fiebich
author_facet Matthias Apweiler
Soraya Wilke Saliba
Jana Streyczek
Thomas Hurrle
Simone Gräßle
Stefan Bräse
Bernd L. Fiebich
author_sort Matthias Apweiler
title Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
title_short Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
title_full Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
title_fullStr Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
title_full_unstemmed Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
title_sort targeting oxidative stress: novel coumarin-based inverse agonists of gpr55
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/53573912c7d940c28090b1526114831b
work_keys_str_mv AT matthiasapweiler targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55
AT sorayawilkesaliba targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55
AT janastreyczek targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55
AT thomashurrle targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55
AT simonegraßle targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55
AT stefanbrase targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55
AT berndlfiebich targetingoxidativestressnovelcoumarinbasedinverseagonistsofgpr55
_version_ 1718432176695934976